Ten-year survival after autologous stem cell transplantation for immunoglobulin light chain amyloidosis.
about
Immunoglobulin light chain amyloidosis: 2013 update on diagnosis, prognosis, and treatmentImmunoglobulin light chain amyloidosis: 2014 update on diagnosis, prognosis, and treatment.Extended follow up of high-dose melphalan and autologous stem cell transplantation after vincristine, doxorubicin, dexamethasone induction in amyloid light chain amyloidosis of the prospective phase II HOVON-41 study by the Dutch-Belgian Co-operativCoexistent multiple myeloma or increased bone marrow plasma cells define equally high-risk populations in patients with immunoglobulin light chain amyloidosisImmunoglobulin light chain amyloidosis.Immunoglobulin light chain amyloidosis: 2016 update on diagnosis, prognosis, and treatment.Proteasome inhibitors in AL amyloidosis: focus on mechanism of action and clinical activity.Heart transplantation in cardiac amyloidosis.Immunoparesis status in immunoglobulin light chain amyloidosis at diagnosis affects response and survival by regimen type.Stringent patient selection improves outcomes in systemic light-chain amyloidosis after autologous stem cell transplantation in the upfront and relapsed setting.Predictors of early treatment failure following initial therapy for systemic immunoglobulin light-chain amyloidosis.Revisiting conditioning dose in newly diagnosed light chain amyloidosis undergoing frontline autologous stem cell transplant: impact on response and survival.Outcomes and treatments of patients with immunoglobulin light chain amyloidosis who progress or relapse postautologous stem cell transplant.Immunoglobulin light chain amyloidosis diagnosis and treatment algorithm 2018.
P2860
Q26827340-1B013FFF-ED77-494C-94A1-8364FBB94859Q34448455-B3C7A6F0-26D8-4489-97EA-5EFFFB87508FQ35571048-6CE7E6ED-A3C1-4DDE-A3DA-913BB9582B0EQ36938784-CEF3F570-D124-43CA-ABBD-85F70C20F060Q38172295-EF543328-ABDF-4DD7-99E9-75654AE57E1FQ38928383-B910C249-0522-4BE2-99D1-4E302DE6E665Q38959241-4E72E0C0-4620-4E9E-A788-F8D8AB5277BDQ39172346-36CCDC0E-FC39-4AC6-A572-E75F0948C3F5Q41433373-84E38571-55D7-47F2-8445-84B864195C73Q43057972-86EAF73C-655C-47B9-813A-E0EB01F8F4C1Q48139614-2430441C-AB0F-48CB-AFF5-4281A08FCCF7Q52777488-676C8D16-0E6A-4CE1-BD7A-D21F0E8370A2Q53067739-FBC23A00-3171-4782-AFA1-899C04A24D04Q55023498-B6A0DBB8-F576-4832-977A-D7C2D14AE3FE
P2860
Ten-year survival after autologous stem cell transplantation for immunoglobulin light chain amyloidosis.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Ten-year survival after autolo ...... bulin light chain amyloidosis.
@en
Ten-year survival after autolo ...... bulin light chain amyloidosis.
@nl
type
label
Ten-year survival after autolo ...... bulin light chain amyloidosis.
@en
Ten-year survival after autolo ...... bulin light chain amyloidosis.
@nl
prefLabel
Ten-year survival after autolo ...... bulin light chain amyloidosis.
@en
Ten-year survival after autolo ...... bulin light chain amyloidosis.
@nl
P2093
P2860
P50
P356
P1433
P1476
Ten-year survival after autolo ...... bulin light chain amyloidosis.
@en
P2093
Francis K Buadi
Shaji K Kumar
Stefan Cordes
William J Hogan
P2860
P304
P356
10.1002/CNCR.27660
P407
P577
2012-06-15T00:00:00Z